Patents Assigned to LFB Biotechnologies
  • Publication number: 20090029393
    Abstract: The present invention relates to a method for preparing an antibody selective for activating antibody Fc region receptors (FcRs) comprising an ITAM motif or motifs (immunoreceptor tyrosine-based activation motif), comprising the steps of obtaining monoclonal antibodies from a hybridoma, from a heterohybridoma or from any animal, plant or human cell line, replacing each of the His 310 and His 435 residues (Cabat numbering) of the Fc region of said antibody with a residue chosen from lysine, alanine, glycine, valine, leucine, isoleucine, proline, methionine, tryptophan, phenylalanine, serine or threonine, and then selecting the antibodies for which the binding to inhibitory FcRs comprising ITIM motifs (immunoreceptor tyrosine-based inhibition motif) is decreased by at least 30%, preferably by at least 50%, 70%, 80% or else by at least 90% relative to the same antibody having a natural Fc region.
    Type: Application
    Filed: December 15, 2006
    Publication date: January 29, 2009
    Applicant: LFB Biotechnologies
    Inventors: Jean-Luc Teillaud, Sylvie Jorieux, Sophie Siberil, Renee Menez, Enrico Stura, Frederic Ducancel